Cristina Morelli

445 total citations
23 papers, 201 citations indexed

About

Cristina Morelli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Cristina Morelli has authored 23 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Cristina Morelli's work include Colorectal Cancer Treatments and Studies (8 papers), Genetic factors in colorectal cancer (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Cristina Morelli is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Genetic factors in colorectal cancer (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Cristina Morelli collaborates with scholars based in Italy, United Kingdom and France. Cristina Morelli's co-authors include Vincenzo Formica, Mario Roselli, Silvia Riondino, Hendrik‐Tobias Arkenau, Francesco Sera, Chiara Cremolini, Anna Patrikidou, Manfredi Tesauro, Kai‐Keen Shiu and Nicola Di Daniele and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Cristina Morelli

21 papers receiving 201 citations

Peers

Cristina Morelli
Crystal Hilger United States
Cristina Morelli
Citations per year, relative to Cristina Morelli Cristina Morelli (= 1×) peers Crystal Hilger

Countries citing papers authored by Cristina Morelli

Since Specialization
Citations

This map shows the geographic impact of Cristina Morelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cristina Morelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cristina Morelli more than expected).

Fields of papers citing papers by Cristina Morelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cristina Morelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cristina Morelli. The network helps show where Cristina Morelli may publish in the future.

Co-authorship network of co-authors of Cristina Morelli

This figure shows the co-authorship network connecting the top 25 collaborators of Cristina Morelli. A scholar is included among the top collaborators of Cristina Morelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cristina Morelli. Cristina Morelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Riondino, Silvia, Vincenzo Formica, Cristina Morelli, et al.. (2023). Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy?. Current Oncology. 30(1). 1220–1231. 8 indexed citations
4.
Formica, Vincenzo, Cristina Morelli, Veronica Conca, et al.. (2023). Irinotecan- vs. Oxaliplatin-Based Doublets in KRASG12C-Mutated Metastatic Colorectal Cancer—A Multicentre Propensity-Score-Matched Retrospective Analysis. Cancers. 15(11). 3064–3064. 2 indexed citations
5.
Signorelli, Carlo, Marta Schirripa, Mario Giovanni Chilelli, et al.. (2023). Sequential treatment with regorafenib and trifluridine/tipiracil in later-line refractory metastatic colorectal cancer: A real-world multicenter retrospective study.. Journal of Clinical Oncology. 41(4_suppl). 45–45.
6.
Morelli, Cristina, Vincenzo Formica, Paolo Bossi, et al.. (2023). Untailored vs. Gender- and Body-Mass-Index-Tailored Skeletal Muscle Mass Index (SMI) to Assess Sarcopenia in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC). Cancers. 15(19). 4716–4716. 4 indexed citations
7.
Formica, Vincenzo, Silvia Riondino, Cristina Morelli, et al.. (2023). HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling. British Journal of Cancer. 129(2). 222–236. 3 indexed citations
8.
Morelli, Cristina, Silvia Riondino, Daniela Fraboni, et al.. (2022). Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation. Cancers. 14(11). 2594–2594. 7 indexed citations
10.
Morelli, Cristina, Vincenzo Formica, Anna Patrikidou, et al.. (2022). Nutritional index for immune-checkpoint inhibitor in patients with metastatic gastro-esophageal junction/gastric cancer. Journal of Gastrointestinal Oncology. 13(5). 2072–2081. 6 indexed citations
11.
Morelli, Cristina, et al.. (2021). BRAF/MEK inhibitors for BRAF V600E-mutant cancers in non-approved setting: a case series. Cancer Chemotherapy and Pharmacology. 87(3). 437–441. 7 indexed citations
12.
Formica, Vincenzo, Cristina Morelli, G Giuliano, et al.. (2021). Health-related quality of life in patients with advanced colorectal cancer: a predictive nomogram including BMI, sex and age. Annals of Palliative Medicine. 10(4). 4252–4261. 6 indexed citations
13.
Formica, Vincenzo, Cristina Morelli, Silvia Riondino, et al.. (2020). Obesity and common pathways of cancer and cardiovascular disease. SHILAP Revista de lepidopterología. 1(3-4). 100065–100065. 15 indexed citations
14.
Morelli, Cristina, Vincenzo Formica, Silvia Riondino, et al.. (2020). Irinotecan or Oxaliplatin: Which is the First Move for the Mate?. Current Medicinal Chemistry. 28(16). 3158–3172. 1 indexed citations
15.
Formica, Vincenzo, Elena Doldo, Silvia Riondino, et al.. (2020). Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients—The Importance of Tissue/Plasma Discordant Cases. Journal of Clinical Medicine. 10(1). 87–87. 11 indexed citations
16.
Formica, Vincenzo, et al.. (2020). A systematic review and meta-analysis of PD-1/PD-L1 inhibitors in specific patient subgroups with advanced gastro-oesophageal junction and gastric adenocarcinoma. Critical Reviews in Oncology/Hematology. 157. 103173–103173. 15 indexed citations
17.
Formica, Vincenzo, Cristina Morelli, Anna Patrikidou, et al.. (2020). Gastric Inflammatory Prognostic Index (GIPI) in Patients with Metastatic Gastro-Esophageal Junction/Gastric Cancer Treated with PD-1/PD-L1 Immune Checkpoint Inhibitors. Targeted Oncology. 15(3). 327–336. 17 indexed citations
18.
Morelli, Cristina, et al.. (2018). Chemotherapy in Patients with Hereditary Angioedema. Anticancer Research. 38(12). 6801–6807. 2 indexed citations
19.
Formica, Vincenzo, G. Del Vecchio Blanco, Elena Doldo, et al.. (2018). Hemoglobin level and XRCC1 polymorphisms to select patients with locally advanced rectal cancer candidate for neoadjuvant chemoradiotherapy with concurrent capecitabine and a platinum salt. Medical Oncology. 35(6). 83–83. 1 indexed citations
20.
Formica, Vincenzo, Cristina Morelli, Patrizia Ferroni, et al.. (2016). Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin. Cancer Biomarkers. 17(3). 335–345. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026